Acrongenomics, Inc. and Molecular Vision, Ltd. (MLV) an Imperial College spin-out company, have announced the demonstration of their BioLED Lab on a Chip technology using MVL’s patented, organic semiconductor technology in a high sensitivity, small size, medical diagnostic device that took place at Imperial College in London, UK on March 8th 2007.
The device has demonstrated its technological capability to measure biomarkers with high sensitivity.
BioLED technology uses semiconductor films located on either side of a microfluidics chip. One film illuminates the chip, where appropriate, while the other film detects an output signal, which is fed to a display.
The demonstrated device used two forms of detection utilizing chemiluminescence and fluorescence to detect different markers of interest.
Acrongenomics & Molecular Vision believe that this technology is capable of further miniaturization along with large scale, low cost manufacturing, which will bring forward disposable, Point Of Care diagnostics for a large range of biomarkers.
Furthermore the companies presented possible design concepts of BioLED technology applications to be used at home, in doctor’s offices and hospitals.